127

Last update : 09/05/2017

REAL.FR - Longitudinal Study on Patients in Alzheimer's Disease Network

Head : Vellas Bruno, Inserm U 1027

Main objective

To ensure regular monitoring of the patient and those close to them in order to assess the cognitive and non-cognitive aspects of the disease.
To analyse treatment methods, as well as drug- and non-drug-related therapy for elderly people with AD across a national sample with diverse socio-cultural contexts. To identify potential treatment issues, such as repeated hospitalisation or emergency institutionalisation.

Inclusion criteria

- Male and female;
- Patient with Alzheimer's-type dementia.

Last update : 09/05/2017

- The Impact of Male Gonadal Dose of Ionising Radiation and Probability of Pregnancy

Head : Slama Remy, U823 Centre de recherche institut Albert Bonniot Équipe: Épidémiologie environnementale appliquée à la reproduction et à la santé respiratoire

Version 1

128

Last update : 09/05/2017

- The Impact of Male Gonadal Dose of Ionising Radiation and Probability of Pregnancy

Head : Slama Remy, U823 Centre de recherche institut Albert Bonniot Équipe: Épidémiologie environnementale appliquée à la reproduction et à la santé respiratoire

Main objective

To determine the effects of ionising radiation on male reproductive function. To assess the risks of ionising radiation on humans concerning the probability of pregnancy.

Inclusion criteria

- Women - between 18 and 60 years old - recognised pregnancy between 1985 and 2000

Last update : 09/05/2017

AlimAdos - Cross-sectional study of dietary behaviours in adolescents

Head : Pardo Véronique

Version 1

129

Last update : 01/01/2019

AlimAdos - Cross-sectional study of dietary behaviours in adolescents

Head : Pardo Véronique

Main objective

To understand the dietary habits of adolescents considering cultural differences and population mixing at work today in France.

Inclusion criteria

Be 12 to 19 years of age and live in the Alsace or Provence-Alpes-Côtes d'Azur region.

Last update : 01/01/2019

- Longitudinal General Population Study: Pulmonary Nodule Detection by Computed Tomography (CT) Scan

Head : Launoy Guy, Cancers et populations

Version 2

130

Last update : 01/01/2019

- Longitudinal General Population Study: Pulmonary Nodule Detection by Computed Tomography (CT) Scan

Head : Launoy Guy, Cancers et populations

Main objective

To prove that the presence of pulmonary nodules (by scan) increases the risk of developing lung cancer.
To prove that there is no relationship between exposure to asbestos and the risk of developing lung cancer.

Inclusion criteria

- Male or female;
- Not-working or retired.

Last update : 01/01/2019

IMPACT - Determinants of the non-control of blood pressure in overweighted treated hypertensive patients

Head : Vignal Franck, Sanofi Aventis

Version 1

131

Last update : 01/01/2019

IMPACT - Determinants of the non-control of blood pressure in overweighted treated hypertensive patients

Head : Vignal Franck, Sanofi Aventis

Main objective

Find the determinants of the non-control of blood pressure in treated hypertensive patients who are overweight or obese compared to treated hypertensive patients of normal weight

Inclusion criteria

Man or woman, over the age of 18 years, Having essential high blood pressure (HBP) treated for at least 1 year, Having a BMI < 25 kg/m² for patients of normal weight, Having a BMI ≥ 25 kg/m² for overweight or obese patients

Last update : 01/01/2019

ARIANE - Arixtra and platelet monitoring (Study of the actual usage of Arixtra® 2, 5 mg in general practice

Head : Leclerc-Zwirn Christel, Laboratoire GSK

Version 1

132

Last update : 01/01/2019

ARIANE - Arixtra and platelet monitoring (Study of the actual usage of Arixtra® 2, 5 mg in general practice

Head : Leclerc-Zwirn Christel, Laboratoire GSK

Main objective

Evaluate and compare in general practice the level of prescription for platelet monitoring of patients receiving Arixtra® 2.5 mg (fondaparinux sodium) or an LMWH (low-molecular-weight heparin) in venous thromboprophylaxis.

Inclusion criteria

• Patient of at least 18 years of age
• Bedridden patient or with reduced mobility
Patient for whom a treatment via ARIXTRA® 2.5 mg or an LMWH is initiated within the framework of venous thromboprophylaxis

Last update : 01/01/2019